Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aeterna Initiates Phase III Study on AEZS-108
Yahoo/Zacks
Saturday, August 3, 2013 - 10:30am
tags:
Aeterna Zentaris, AEZS-108, endometrial cancer
Questcor Going Up Even After Earnings
Seeking Alpha
Saturday, August 3, 2013 - 10:29am
tags:
Questcor Pharmaceuticals, earnings
Wider-than-Expected Loss at Endocyte
Yahoo/Zacks
Saturday, August 3, 2013 - 10:28am
tags:
Endocyte, earnings
BioCryst: The Next Orphan Drug $1B+ Company
Seeking Alpha
Saturday, August 3, 2013 - 10:27am
tags:
Biocryst, BCX4161, angioedema
Biogen Idec Product Pipeline Will Propel It Higher
Seeking Alpha
Saturday, August 3, 2013 - 10:26am
tags:
Biogen Idec
Johnson & Johnson Receives Boost in This Key Market
Motley Fool
Saturday, August 3, 2013 - 10:24am
tags:
Stelara, psoriatic arthritis, JNJ
The Deal: Pfizer's 3-Way Split Preps Company Long Term
The Street
Saturday, August 3, 2013 - 10:17am
tags:
Pfizer
These Pharmaceutical Giants Are Teetering Dangerously Near The Patent Cliff
Motley Fool
Saturday, August 3, 2013 - 10:16am
tags:
Pfizer, Eli Lilly, Bristol-Myers Squibb, patent cliff
This Company Is Tackling Multiple Sclerosis Head On
Motley Fool
Saturday, August 3, 2013 - 10:15am
tags:
MS, multiple sclerosis, Genzyme, Lemtrada, Sanofi
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Saturday, August 3, 2013 - 10:14am
tags:
Regeneron, earnings
Innovative KaloBios Pharmacuticals Could Be A Lucrative Buy
Seeking Alpha
Saturday, August 3, 2013 - 10:12am
tags:
KaioBios Pharmaceuticals
GlaxoSmithKline diabetes drug faces U.S. approval delay
Reuters
Saturday, August 3, 2013 - 10:11am
tags:
albiglutide, type 2 diabetes, diabetes
3 Things You Need to Know From Astex's Q2 Earnings
Motley Fool
Saturday, August 3, 2013 - 10:10am
tags:
Astex, earnings
Johnson & Johnson Is Too Expensive
Yahoo/The Street
Saturday, August 3, 2013 - 10:08am
tags:
JNJ
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Friday, August 2, 2013 - 1:15pm
tags:
earnings, Regeneron
Celsion's Q2 Earnings: What I'm Expecting
Seeking Alpha
Friday, August 2, 2013 - 1:04pm
tags:
Celsion, earnings
Nothing to See Here, No Huge Sales Yet
Motley Fool
Friday, August 2, 2013 - 1:00pm
tags:
Arena Pharmaceutical, Belviq, Eisai, obesity
Progress In Asthma Drug Therapy From A Patient's View
Forbes
Friday, August 2, 2013 - 12:09pm
tags:
asthma, patients, Advair
Immunogen Earnings: Here’s Why Shares are Up Now
Wall St. Cheat Sheet
Friday, August 2, 2013 - 11:58am
tags:
Immunogen, earnings
Innovative KaloBios Pharmacuticals Could Be A Lucrative Buy
Seeking Alpha
Friday, August 2, 2013 - 11:50am
tags:
KaloBios

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.